Congratulations to Max Cigrang on the acceptance of his thesis!
Congratulations to Max Cigrang on the acceptance of his thesis, directed by Frédéric Coin : " Targeting Transcriptional Addiction in Cutaneous Melanoma ".
By using different strategies to specifically target dysregulated gene expression programs in melanoma cells, Max Cigrang showed during his thesis that the use of transcriptional inhibitors might be a viable therapeutic option for this cancer.
Want to know more ? You can read this article published in Embo Reports : https://pubmed.ncbi.nlm.nih.gov/34296805/
During his time at the IGBMC, the PhD student was able to develop a strong understanding of cancer research and functional genomics (RNA-seq, ChIP-seq, Cut & tag) as well as project management and student supervision. He also won the prize for best poster at the 21st Science Day organised by La Ligue contre le Cancer, on 9 November 2021.
The expertise and investment of our Genomeast, cell culture, flow cytometry, cell screening and hispathology platforms enabled this project to be carried out with the multi-level analyses required. Thanks also to PharmaMar for its collaboration with him.
Max Cigrang is staying on at the IGBMC for a one-year post-doctorate to complete various projects. After that, the young researcher hopes to pursue his career in cancer research!